Crestline Management, LP Edwards Lifesciences Corp Transaction History

Crestline Management, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $1.7 Million - $2.14 Million	-16,656 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $896,379 - $1.1 Million	-8,427 Reduced 33.6%	16,656 $2.16 Million
Q3 2021 Nov 12, 2021	BUY	$102.91 - $122.75 $2.58 Million - $3.08 Million	25,083 New	25,083 $2.84 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.